INSIGHTS ON DRUG DEVELOPMENT
-
Ushering In A New Era Of Human-Relevant Drug Discovery
With most drug candidates failing before approval, researchers need better ways to predict human responses. Gain insight into how advances in human-relevant modeling are helping improve decisions.
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
mRNA Vaccines And Therapeutics: Current Trends And Perspectives
Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.
-
In Vivo Testing Of Nasal Dosage Forms
Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
-
Driving Optimization Through Connected Laboratory Environments8/31/2026
Discover how connected laboratory data and predictive modeling can strengthen process control, improve yield, and more, creating a faster and more resource-efficient approach.
-
Application Of LC-UV/MS Workflows To Increase Efficiency7/29/2025
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
Your Guide To Precise And Robust Separation Methods11/12/2025
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety9/16/2025
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
-
Where Speed Meets Complexity In Bioprocess Development6/18/2026
Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.
DRUG DEVELOPMENT SOLUTIONS
-
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
Poor solubility derails ~80% of molecules. Thermo Fisher Scientific's Quadrant 2 platform uses AI/ML to predict the right formulation strategy before lab work begins.